Samsung is recognizing Española Valley High School for its student’s efforts to help people dealing with Parkinson’s Disease.

The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...

A new study published in the Journal of Medical Internet Research has found that regular participation in dance classes can ...

Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...

Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...

Sharon Osbourne shared an update on Ozzy Osbourne’s battle with Parkinson’s disease before his final show with Black Sabbat ...

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal stimulation.

We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...

People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.